-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - Upon continued treatment, in the open-label
extension (Period C), the types of adverse events were similar … the
etanercept registrational study had an 8-year extension, during which
both efficacy and safety continued … following sentence be added: “This trial
included an 8-year extension, during which efficacy and safety
continued … Most
of the responding patients who continued etanercept therapy without
interruption have maintained
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-227-noninvasive-nonpharm-chronic-pain-comments.pdf
April 16, 2020 - AHRQ
contracted investigators were forced to "assume" that usual
therapy was in many cases continued … https://www.ncbi.nlm.nih.gov/pubmed/31005246
https://www.ncbi.nlm.nih.gov/pubmed/31659663
Response continued … The NCCAOM and the ASA are grateful for AHRQ’s continued
attention to, and acknowledgement of, acupuncture
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Diabetes Mellitus
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 07: Diabetes Mellitus
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
April 01, 2021 - mu-receptor blockade and enable analgesic effects of other opioid agonists.31 Methadone
generally can be continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief3-SUD.pdf
April 01, 2021 - mu-receptor blockade and enable analgesic effects of other opioid agonists.31 Methadone
generally can be continued
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d3.xlsx
January 01, 2025 - Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D3 Tables
Table D-3. Outcomes
Author, year Key Questions Intervention Arm Group Control Arm Group Outcome domain Outcome domain comment Overall survival Prostate cancer-specific survival Prostate cancer-specific survival commen…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_clinician.pdf
September 01, 2016 - Overview of Clinical Research Evidence (Continued)
Table 4: Common Adverse Effects Reported in Studies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
April 01, 2010 - Table 1
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists health ca…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0094_04-09-2009.pdf
January 01, 2009 - Effective Health Care
Topic Number(s): 0051
Document Completion Date: 6-12-09
1
Results of Topic Selection Process & Next Steps
Therapies for autism spectrum disorders will go forward for refinement as a comparative effectiveness
or effectiveness review. The scope of this topic, including pop…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
June 01, 2011 - Details of applications (i=9) in VOI studies [k=7] using “limited modeling” approaches to VOI (continued … Details of applications [k=9] in VOI studies [n=12] using “no modeling” approaches to VOI (continued) … Details of applications [k=9] in VOI studies [n=12] using “no modeling” approaches to VOI (continued) … Details of applications [k=9] in VOI studies [n=12] using “no modeling” approaches to VOI (continued) … Details of applications [k=9] in VOI studies [n=12] using “no modeling” approaches to VOI (continued)
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - Summary of evidence in studies addressing effectiveness of pharmacologic
interventions (continued) … Summary of evidence in studies addressing effectiveness of pharmacologic
interventions (continued) … Summary of evidence in studies addressing effectiveness of pharmacologic
interventions (continued) … Summary of evidence in studies addressing effectiveness of surgical interventions
(continued)
21 … Summary of evidence in studies addressing effectiveness of surgical interventions
(continued)
Applicability
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
January 01, 2012 - treatment period comparing the drug (20 or 40
mcg/day) with twice-daily exenatide injections, treatment continued … Eighty-five percent of enrolled patients continued and the company
reported in September 2011 that
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-appendix-d.xlsx
January 01, 2024 - Data extraction tools
PMID Authors Title PubYear Tool_name Environment Access Model_name Model_type Training ESP_Task Specific_ESP_task Prompts_reported Inputs Outputs Notes Reference_standard Validation N_runs Reports_tested Outcome_description Summary_measure Kappa Kappa_dispersion Correctness Correctness_low Correc…
-
effectivehealthcare.ahrq.gov/sites/default/files/carman-presentation.pdf
May 29, 2025 - Carman-notes-151021 copy-Teresa
We got invited to submit a publication to Health Affairs in 2013 that really asked us to
think, “How do we think about patient and
family engagement? How can
we think about
what are the major issues in
this area?” We've been
thinking about this concept for a long
time, …
-
effectivehealthcare.ahrq.gov/products/indirect-comparisons/research-2013
-
effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_goalsetting.pdf
May 29, 2025 - Slide 1
Goal Setting
Jyoti Gupta, MPH,
Senior Public Engagement Associate
Public Agenda
1
Purposes of Goal Setting
• To choose the right strategies and
methodologies for engagement
• To be clear and honest about what one
can reasonably expect to be the outcomes
2
Goals of Del…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
July 01, 2009 - Important next steps include continued efforts to build the DARTNet research portfolio,
secure additional … and operational infrastructure to conduct
increasingly complex practical clinical trials and have continued … AHRQ is the most important funding source for the network and its continued
support in DARTNet’s second
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-executive-summary.pdf
July 01, 2024 - Continued on page 2
2
Background and Purpose
During the perinatal period (defined as
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
February 10, 2016 - Source: www.effectivehealthcare.ahrq.gov
Published online: November 9, 2015
Evidence-‐‑based
Practice
Center
Systematic
Review
Protocol
Project Title: Tonsillectomy for Obstructive Sleep-Disordered Breathing or Recurrent Throat Infection
in Children
Initial publication date if applicable…